Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists.

Autor: Arhancet GB; St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, St. Louis, Missouri 63017, USA. graciela.arhancet@novusint.com, Woodard SS, Iyanar K, Case BL, Woerndle R, Dietz JD, Garland DJ, Collins JT, Payne MA, Blinn JR, Pomposiello SI, Hu X, Heron MI, Huang HC, Lee LF

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2010 Aug 26; Vol. 53 (16), pp. 5970-8.

Early cardiac mineralocorticoid receptor-regulated genes: identifying the not so usual suspects.

Autor: Bolten CW; Pfizer Molecular Pharmacology, 700 Chesterfield Parkway, Chesterfield, Missouri 63017, USA. charles.w.bolten@pfizer.com, Heron MI

Publikováno v: Endocrinology [Endocrinology] 2006 Jul; Vol. 147 (7), pp. 3181-2.

Early and late effect of neonatal hypo- and hyperthyroidism on coronary capillary geometry and long-term heart function in rat.

Autor: Heron MI; Department of Physiology, Faculty of Medicine, University of Ottawa, Ont., Canada., Kolar F, Papousek F, Rakusan K

Publikováno v: Cardiovascular research [Cardiovasc Res] 1997 Jan; Vol. 33 (1), pp. 230-40.

Entrepreneurial Curiosity, Innovativeness of the Entrepreneur, and Company Growth.

Autor: Peljko, Žiga¹ (AUTHOR), Auer Antončič, Jasna² (AUTHOR) jasna.auer@fm-kp.si

Publikováno v: Behavioral Sciences (2076-328X). Nov2022, Vol. 12 Issue 11, p424. 21p.